Position in RPRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$6,952
+$1,916 QoQ
Shares Held
124
+18.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#590
of 641 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $228,442 across 29 Biotechnology names. RPRX ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210 | $104,313 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
61 | $38,035 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66 | $19,867 | |
| 4 | INCY |
Incyte Corp
|
113 | $12,809 | |
| 5 | MRNA |
Moderna, Inc.
|
124 | $8,683 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
90 | $7,335 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
124 | $6,952 | |
| 8 | CYTK |
Cytokinetics Inc
|
71 | $6,048 |
All Filings in RPRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,952 | 124 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $5,036 | 105 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,018 | 104 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $3,669 | 104 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $3,747 | 104 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,774 | 57 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $994 | 39 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $339 | 12 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $342 | 13 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $151 | 5 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $56 | 2 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||